Clinical Trial

A Study Comparing SHR-3167 and Insulin Degludec in Type 2 Diabetic Subjects Treated With Basal Insulin With or Without Oral Antidiabetic Drugs

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated November 18, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to evaluate the glycemic control and safety of SHR-3167 and Insulin Degludec in type 2 diabetic participants treated with basal insulin with or without oral antidiabetic drugs.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-05.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-11-14
Trial Details
NCT Number NCT07018453
Lead Sponsor Jiangsu HengRui Medicine Co., Ltd.
Conditions Type 2 Diabetes Mellitus
Enrollment 173 participants
Start Date 2025-07-16
Primary Completion 2026-02 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2025-11-18